Live Breaking News & Updates on 2 dg drug

Stay informed with the latest breaking news from 2 dg drug on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in 2 dg drug and stay connected to the pulse of your community

IICT, Lee Pharma sign agreement for synthesis of 2-DG drug for COVID-19 patients

It has been found to help speed up recovery and reduce oxygen dependence and Dr. Reddy’s Laboratories has launched the drug in the form of sachets

India , Hyderabad , Andhra-pradesh , Visakhapatnam , Lee-pharma , Centre-for-cellular , Lee-pharma-ltd , Indian-institute-of-chemical-technology , Indian-institute , Chemical-technology , Drug-controller-general , Molecular-biology

DRDO invites EoIs for 2-DG technology transfer for bulk production

Last date to submit EoI applications through email is June 17. EoI submitted by industries will be scrutinised by a Technical Assessment Committe, a DRDO statement said

India , Sudhir-chandana , Technical-assessment-committee , Development-organisation , Defence-research , First-come-served-basis , Active-pharmaceutical-ingredient , Drug-licencing-authorities , Good-manufacturing-practices , Drdo-invites-eois , 2-dg-technology-transfer , Bulk-production

DRDO invites EoI to transfer technology of 2-DG drug for bulk production | India News

India News: The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients,

Hyderabad , Andhra-pradesh , India , Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , First-come-served-basis , Active-pharmaceutical-ingredient

DRDO's anti-covid drug 2-DG launched; checkout efficacy, price, dosage

DRDO's anti-covid drug 2-DG launched; checkout efficacy, price, dosage
Anti-Covid oral drug has been developed by DRDO's leading laboratory -- Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy's Laboratories
BusinessToday.In | May 17, 2021 | Updated 12:57 IST
Defence minister Rajnath Singh and health minister Harsh Vardhan. Photo Credit: ANI
Union defence minister Rajnath Singh today released the first batch of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), which has been granted emergency approval by the Drug Controller General of India (DCGI). The anti-Covid oral drug has been developed by the Defence Research and Development Organisation's (DRDO's) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories.

India , Bharat , Sudhir-chandna , Rajnath-singh , Sudhir-chandana , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Drug-controller-general , Nuclear-medicine , Allied-sciences , Bharat-biotech